{
  "docId": "019de076-7d6c-774e-85e8-ffe50da37251",
  "docSlug": "0b0d701714d17efa78c23c196990e90c",
  "documentTitle": "Genelux | Investor Presentation Deck | 37 slides",
  "authorId": "genelux",
  "authorName": "Genelux",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 36,
  "pageCount": 37,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "The slide uses a combination of immunological data (ELISPOT) and clinical imaging data (SLD) to show causality between immune response and tumor shrinkage.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-7d6c-774e-85e8-ffe50da37251/36",
  "deckHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251",
  "deckJsonHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251.json",
  "deckAnchorHref": "/decks/019de076-7d6c-774e-85e8-ffe50da37251#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.62,
        "y": 0.12
      },
      "kind": "chart",
      "text": "IFN-gamma secreting cells / 100,000 PBMCs at Baseline, Week 6, and Week 30",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c224d2e-21e9-4633-93e6-8cada171253c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.62,
        "y": 0.52
      },
      "kind": "chart",
      "text": "SLD of target lesions over time",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a71a9d24-6def-4b53-86a7-5dff5b1db9b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.35,
        "y": 0.52
      },
      "kind": "diagram",
      "text": "Last Chemotherapy -> Progressive disease -> GL-ONC1 Tx -> Partial response -> Stable disease",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a7f425c-5745-4398-a86d-4591b8b41d64",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.28,
        "x": 0.04,
        "y": 0.215
      },
      "kind": "list",
      "text": "Key Takeaways: Off-the-Shelf Personalized Medicine: Single Agent generates Individualized Results. Olvi-Vec induces favorable & long-lasting Tumor-specific T-cell Response (TSTcR)... Documented OR from Olvi-Vec treatment after failure of last chemotherapy",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98d49e68-0fa6-490a-b6da-0fcb54afffe2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.35,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "Case Report (Pt #15A-05). Heavily pre-treated: 9 prior regimens of chemo+Avastin; no pre-existing tumor-specific T-cells. Post treatment: Consequential amount (~3%) of all activatable T cells at Week 30 are tumor-specific T-cells",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95275fd5-f125-4c5c-945c-2d3c9ca287db",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.94,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Long-lasting, Tumor-specific T cell response corresponds to tumor reduction",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22be8c1d-77a9-4fe0-9082-bd83d5e6210c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "1f8ba478-3a7c-4551-ae10-d5d8c1a1d785",
      "evidence": "Shows patient state before and after treatment to demonstrate efficacy.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}